Emactuzumab
According to the NCI website Emactuzumab is a humanized monoclonal antibody directed against the tyrosine kinase receptor colony stimulating factor 1 receptor (CSF1R; CSF-1R; CD115). Check for active clinical trials using this agent.
The IUPHAR/BPS Guide to PHARMACOLOGY